Market Tracker

02/24 5:16pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

16.18
Delayed Data
As of Feb 24
 -0.40 / -2.41%
Today’s Change
13.00
Today|||52-Week Range
86.50
+11.43%
Year-to-Date
Berkshire Letter Highlights: Buffett Hates Hedge Funds, Likes Immigrants And The US O...
10:41am / Investing Channel - Paid Partner Content
Silver Point Capital L.P. Buys Basic Energy Services, Key Energy Services, Penn Virgi...
Feb 22 / GuruFocus News - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Feb 23 / GuruFocus News - Paid Partner Content
Valeant Acquires Eyegate Licensing Rights
Feb 21 / TheStreet.com - Paid Partner Content
Allergan Lacks Interest in Valeant
Feb 23 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Alle...
Feb 21 / Zacks.com - Paid Partner Content
Frontrunning: February 23
Feb 23 / Investing Channel - Paid Partner Content
This Guru Loves Valeant; Should You?
Feb 20 / GuruFocus News - Paid Partner Content
Futures Flat, Global Stocks Near Record High After Minutes Fail To Spark Dollar Rally
Feb 23 / Investing Channel - Paid Partner Content
Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.
Feb 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close16.58
Today’s open16.42
Day’s range16.10 - 16.53
Volume10,635,267
Average volume (3 months)17,384,282
Market cap$5.5B
Dividend yield--
Data as of 4:01pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-46.60%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-1.09-2.00%
IONSIonis Pharmaceutical...+0.24+0.54%
TAROTaro Pharmaceutical ...-2.36-1.98%
ACADACADIA Pharmaceutica...-0.68-1.72%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$1.21
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts